Author: Dino Mustafić

March 21, 2020 Off

FDA warns about fraudulent COVID-19 test kits for home use

By Dino Mustafić

The U.S. Food and Drug Administration is actively and aggressively monitoring the market for any firms marketing products with fraudulent coronavirus (COVID-19) diagnostic, prevention and treatment claims as part of our ongoing efforts to protect public health during this pandemic. As a result of these activities, the agency is beginning to see unauthorized fraudulent test kits that are being marketed to test for COVID-19 in the home.

March 18, 2020 Off

Oxford Biomedica, Juno Therapeutics in LentiVector deal

By Dino Mustafić

Oxford Biomedica has signed a new Licence and Clinical Supply Agreement (LSA) with Bristol-Myers Squibb’s company, Juno Therapeutics to use Oxford Biomedica’s LentiVector platform for its application in CAR-T and TCR-T programmes in oncology and other indications.

March 15, 2020 Off

– Opinion: Could Trump prevent spending $50Bn?

By Dino Mustafić

American president Donald Trump has announced radical measures last week; closing entering the USA for European citizens, curbing flights in general, and has announced a national emergency. Only two weeks earlier he was skeptical about the outbreak of the coronavirus in the USA.

March 13, 2020 Off

IBM Watson Health and EBSCO partner up

By Dino Mustafić

IBM Watson Health and EBSCO Information Services Thursday announced a strategic collaboration aimed towards enhancing clinical decision support (CDS) and operations for healthcare providers and health systems.